Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк.filedCriticalПфайзер Инк.
Priority claimed from PCT/IB2009/053626external-prioritypatent/WO2010023594A1/en
Publication of UA103626C2publicationCriticalpatent/UA103626C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compounds of Formula (1) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).The compounds disclosed herein are useful for the prevention and treatment of obesity and its associated co-morbidities, in particular type II (type 2) diabetes.
MACROCICLICAL COMPOUNDS DERIVED FROM 6-ARIL-4-MERCAPTO- [1.3.5] TRIAZINA / [1.3] PIRIMIDIN-2-AMINA; PHARMACEUTICAL COMPOSITION, USEFUL IN THE TREATMENT OF CANCER.